PCR Technologies Market 2028 By Technology, Product, Application, End User, and Geography | The Insight Partners

report image

PCR Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Real-time PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR), Hot-start PCR, and Other PCR); Product (Reagents and Consumables, Instruments, Software and Services); Application (Clinical Application, Research Application, and Forensic Application); End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, and Academic and Research Institutions), and Geography

Report Code: TIPRE00003069 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics are just a few of the disciplines where PCR technology are used. Furthermore, in the forensics section, these technologies are utilized to identify criminals and children's identities. Middle ear infections, AIDS, tuberculosis, and Lyme disease are among the disorders that can be diagnosed using the technology. Rising demand for customised and precision medicine, increasing application in clinical diagnostics, and technological improvements and applications in drug development are among the primary drivers driving the PCR technology market's growth.


The "Global PCR Technologies Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the PCR technologies market with detailed market segmentation by technology, product, application, end user, and geography. The report provides key statistics on the market status of the leading PCR technologies market players and offers key trends and opportunities in the market.


  •   Based on technology, the market is bifurcated into real-time PCR (qPCR), digital PCR (dPCR), reverse transcription PCR (RT-PCR), hot-start PCR, and other PCR
  •   Based on product, the market is bifurcated into reagents and consumables, instruments, and software and services
  •   Based on application, the market is bifurcated into clinical application, research application, forensic application
  •   Based on end user, the market is bifurcated into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, and academic and research institutions



  •   Growing incidence of target infectious diseases and genetic disorders
  •   Advancements in PCR technologies


  •   High device cost


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The PCR technologies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the PCR technologies market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the PCR technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from PCR technologies market are anticipated to lucrative growth opportunities in the future with the rising demand for PCR technologies in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the PCR technologies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Thermo Fisher Scientific Inc.
  •   Takara Bio Inc.
  •   Fluidigm Corporation
  •   F. Hoffmann-LA Roche AG
  •   Bio-Rad Laboratories, Inc.
  •   Agilent Technologies, Inc.
  •   Biomerieux S.A.
  •   LGC Limited
  •   Qiagen N.V.
  •   Promega Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. Thermo Fisher Scientific Inc.
2. Takara Bio Inc.
3. Fluidigm Corporation
4. F. Hoffmann-LA Roche AG
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies, Inc.
7. Biomerieux S.A.
8. LGC Limited
9. Qiagen N.V.
10. Promega Corporation
11. Danaher Corporation
12. Eppendorf AG
13. Analytik Jena AG
14. Merck KGaA
15. Abbott Laboratories
16. Promega
17. Siemens Healthcare
18. Kapa Biosystems
19. Clontech Laboratories
20. Cepheid
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount